Literature DB >> 31974565

HLA Class II Allele Analyses Implicate Common Genetic Components in Type 1 and Non-Insulin-Treated Type 2 Diabetes.

Thomas Jacobi1, Lucas Massier1, Nora Klöting1, Katrin Horn2,3, Alexander Schuch2, Peter Ahnert2, Christoph Engel2,3, Markus Löffler2, Ralph Burkhardt3,4, Joachim Thiery3,5, Anke Tönjes6, Michael Stumvoll1,6, Matthias Blüher1,6, Ilias Doxiadis7, Markus Scholz1,2,3, Peter Kovacs1,6.   

Abstract

CONTEXT: Common genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of HLA class II genes in the pathophysiology of type 1 diabetes, the aim of the present study was to test the association of high density imputed human leukocyte antigen (HLA) genotypes with type 2 diabetes. OBJECTIVES AND
DESIGN: Three cohorts (Ntotal = 10 413) from Leipzig, Germany were included in this study: LIFE-Adult (N = 4649), LIFE-Heart (N = 4815) and the Sorbs (N = 949) cohort. Detailed metabolic phenotyping and genome-wide single nucleotide polymorphism (SNP) data were available for all subjects. Using 1000 Genome imputation data, HLA genotypes were imputed on 4-digit level and association tests for type 2 diabetes, and related metabolic traits were conducted.
RESULTS: In a meta-analysis including all 3 cohorts, the absence of HLA-DRB5 was associated with increased risk of type 2 diabetes (P = 0.001). In contrast, HLA-DQB*06:02 and HLA-DQA*01:02 had a protective effect on type 2 diabetes (P = 0.005 and 0.003, respectively). Both alleles are part of the well-established type 1 diabetes protective haplotype DRB1*15:01~DQA1*01:02~DQB1*06:02, which was also associated with reduced risk of type 2 diabetes (OR 0.84; P = 0.005). On the contrary, the DRB1*07:01~DQA1*02:01~DQB1*03:03 was identified as a risk haplotype in non-insulin-treated diabetes (OR 1.37; P = 0.002).
CONCLUSIONS: Genetic variation in the HLA class II locus exerts risk and protective effects on non-insulin-treated type 2 diabetes. Our data suggest that the genetic architecture of type 1 diabetes and type 2 diabetes might share common components on the HLA class II locus. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HLA class II; association; genotype imputation; haplotype; single nucleotide polymorphism; type 1 diabetes; type 2 diabetes

Year:  2020        PMID: 31974565     DOI: 10.1210/clinem/dgaa027

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Influence of Insulin Receptor Single Nucleotide Polymorphisms on Glycaemic Control and Formation of Anti-Insulin Antibodies in Diabetes Mellitus.

Authors:  Laura Massarenti; Christina Aniol-Nielsen; Christian Enevold; Henrik Toft-Hansen; Claus Henrik Nielsen
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

2.  A previously unappreciated polymorphism in the beta chain of I-As expressed in autoimmunity-prone SJL mice: Combined impact on antibody, CD4 T cell recognition and MHC class II dimer structural stability.

Authors:  Katherine A Richards; Courtney Lavery; Grant L J Keller; Jim Miller; Brian M Baker; Andrea J Sant
Journal:  Mol Immunol       Date:  2022-01-05       Impact factor: 4.174

3.  Genome-wide discovery for diabetes-dependent triglycerides-associated loci.

Authors:  Margaret Sunitha Selvaraj; Kaavya Paruchuri; Sara Haidermota; Rachel Bernardo; Stephen S Rich; Gina M Peloso; Pradeep Natarajan
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

4.  Class I MHC Polymorphisms Associated with Type 2 Diabetes in the Mexican Population.

Authors:  Paola Mendoza-Ramírez; Mildred Alejandra López-Olaiz; Adriana Lizeth Morales-Fernández; María Isabel Flores-Echiveste; Antonio de Jesus Casillas-Navarro; Marco Andrés Pérez-Rodríguez; Felipe de Jesús Orozco-Luna; Celso Cortés-Romero; Laura Yareni Zuñiga; María Guadalupe Sanchez Parada; Luis Daniel Hernandez-Ortega; Arieh Roldán Mercado-Sesma; Raúl C Baptista-Rosas
Journal:  Genes (Basel)       Date:  2022-04-27       Impact factor: 4.141

Review 5.  Human Leukocyte Antigen (HLA) System: Genetics and Association with Bacterial and Viral Infections.

Authors:  Sadeep Medhasi; Narisara Chantratita
Journal:  J Immunol Res       Date:  2022-05-26       Impact factor: 4.493

6.  Alterations in Biomarkers Related to Glycemia, Lipid Metabolism, and Inflammation up to 20 Years Before Diagnosis of Type 1 Diabetes in Adults: Findings From the AMORIS Cohort.

Authors:  Katharina Herzog; Tomas Andersson; Valdemar Grill; Niklas Hammar; Håkan Malmström; Mats Talbäck; Göran Walldius; Sofia Carlsson
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

7.  Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma.

Authors:  Hanna Karhapää; Siru Mäkelä; Hanna Laurén; Marjut Jaakkola; Camilla Schalin-Jäntti; Micaela Hernberg
Journal:  Endocr Connect       Date:  2022-02-04       Impact factor: 3.335

Review 8.  Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.

Authors:  Mara Dierssen; Marta Fructuoso; María Martínez de Lagrán; Marzia Perluigi; Eugenio Barone
Journal:  Front Neurosci       Date:  2020-07-08       Impact factor: 4.677

9.  Epitope Mapping of Pathogenic Autoantigens on Sjögren's Syndrome-Susceptible Human Leukocyte Antigens Using In Silico Techniques.

Authors:  Shivai Gupta; Danmeng Li; David A Ostrov; Cuong Q Nguyen
Journal:  J Clin Med       Date:  2022-03-18       Impact factor: 4.241

10.  Analysis of HLA Variants and Graves' Disease and Its Comorbidities Using a High Resolution Imputation System to Examine Electronic Medical Health Records.

Authors:  Wen-Ling Liao; Ting-Yuan Liu; Chi-Fung Cheng; Yu-Pao Chou; Tzu-Yuan Wang; Ya-Wen Chang; Shih-Yin Chen; Fuu-Jen Tsai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.